7-5902743-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_015622.6(CCZ1):c.521G>A(p.Arg174Gln) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000283 in 1,591,738 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0000067 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000031 ( 0 hom. )
Consequence
CCZ1
NM_015622.6 missense, splice_region
NM_015622.6 missense, splice_region
Scores
3
6
7
Splicing: ADA: 0.9664
1
1
Clinical Significance
Conservation
PhyloP100: 6.99
Genes affected
CCZ1 (HGNC:21691): (CCZ1 homolog, vacuolar protein trafficking and biogenesis associated) Enables guanyl-nucleotide exchange factor activity. Predicted to be involved in vesicle-mediated transport. Located in intracellular membrane-bounded organelle. Part of Mon1-Ccz1 complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCZ1 | NM_015622.6 | c.521G>A | p.Arg174Gln | missense_variant, splice_region_variant | 6/15 | ENST00000325974.9 | NP_056437.4 | |
CCZ1 | XM_047420465.1 | c.521G>A | p.Arg174Gln | missense_variant, splice_region_variant | 6/11 | XP_047276421.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCZ1 | ENST00000325974.9 | c.521G>A | p.Arg174Gln | missense_variant, splice_region_variant | 6/15 | 1 | NM_015622.6 | ENSP00000325681.6 | ||
CCZ1 | ENST00000628813.2 | c.*190G>A | splice_region_variant | 5/14 | 2 | ENSP00000486988.1 | ||||
CCZ1 | ENST00000628813.2 | c.*190G>A | 3_prime_UTR_variant | 5/14 | 2 | ENSP00000486988.1 | ||||
CCZ1 | ENST00000483394.1 | n.148G>A | splice_region_variant, non_coding_transcript_exon_variant | 1/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.00000668 AC: 1AN: 149744Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
149744
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000338 AC: 8AN: 236898Hom.: 0 AF XY: 0.0000390 AC XY: 5AN XY: 128218
GnomAD3 exomes
AF:
AC:
8
AN:
236898
Hom.:
AF XY:
AC XY:
5
AN XY:
128218
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000305 AC: 44AN: 1441994Hom.: 0 Cov.: 31 AF XY: 0.0000321 AC XY: 23AN XY: 716698
GnomAD4 exome
AF:
AC:
44
AN:
1441994
Hom.:
Cov.:
31
AF XY:
AC XY:
23
AN XY:
716698
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000668 AC: 1AN: 149744Hom.: 0 Cov.: 32 AF XY: 0.0000137 AC XY: 1AN XY: 72944
GnomAD4 genome
AF:
AC:
1
AN:
149744
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
72944
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.521G>A (p.R174Q) alteration is located in exon 6 (coding exon 6) of the CCZ1 gene. This alteration results from a G to A substitution at nucleotide position 521, causing the arginine (R) at amino acid position 174 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
T
MetaRNN
Uncertain
D
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
D
Sift4G
Uncertain
D
Vest4
MutPred
Gain of ubiquitination at K170 (P = 0.0434);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at